Free Trial
NASDAQ:PEPT

REX Peptide ETF (PEPT) Price, Holdings, & News

$27.01 +0.12 (+0.45%)
As of 10/30/2026 03:19 PM Eastern

About REX Peptide ETF (NASDAQ:PEPT)

Advanced

Key Stats

Today's Range
$26.86
▼
$27.21
50-Day Range
N/A
52-Week Range
$25.06
▼
$27.21
Volume
7,601 shs
Average Volume
8,750 shs
Market Capitalization
$1.89 million
Assets Under Management
N/A
Dividend Yield
N/A
Net Expense Ratio
0.65%
Aggregate Rating
N/A

ETF Overview

REX Peptide ETF (NASDAQ: PEPT) is an exchange-traded fund designed to provide targeted exposure to companies involved in the development, production, and commercialization of peptide-based medicines and related technologies. Rather than operating as a traditional company, the fund holds a portfolio of businesses participating in the broader peptide therapeutics industry.

The fund’s investment focus may include pharmaceutical and biotechnology companies developing peptide treatments, as well as businesses supporting peptide research, drug discovery, manufacturing, delivery systems, and related healthcare applications. Peptide-based therapies are used or studied across areas such as metabolic disorders, obesity, diabetes, oncology, and other chronic or specialized medical conditions.

PEPT is sponsored by REX Shares, an investment-management platform offering exchange-traded products. The ETF is listed on Nasdaq and is intended for investors seeking focused exposure to the peptide medicine ecosystem through a single publicly traded fund rather than selecting individual companies.

AI Generated. May Contain Errors.

REX Peptide ETF Expenses

TypePEPTTheme ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.65%0.57%0.57%0.54%0.53%
Other Expenses0.00%0.57%0.53%0.38%0.54%
Total Expense0.65%0.72%0.75%0.69%0.73%
Fee Waiver0.00%-0.72%-0.67%-0.41%-0.67%
Net Expense0.65%0.60%0.63%0.61%0.60%
Receive PEPT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for REX Peptide ETF and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PEPT ETF News Headlines

No headlines for this company have been tracked by MarketBeat.com

PEPT ETF - Frequently Asked Questions

REX Peptide ETF's stock was trading at $27.01 on October 30, 2026. Since then, PEPT stock has increased by 0.0% and is now trading at $27.01.

Shares of PEPT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Fund Details

Issuer
REX Advisers
Fund Name
REX Peptide ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:PEPT
Inception Date
10/12/2026
Fund Manager
Matthew Pelletier, Matthew Holcomb

Fund Focus

Asset Class
Equity
Benchmark
VettaFi Peptide Index
Category
Strategy
Focus
Theme
Development Level
Developed Markets
Region
Global
Number of Holdings
104

Fund Statistics

Assets Under Management
$0.00
Average Daily Volume
$0.00
Discount/Premium
0.00%

Administrator, Advisor and Custodian

Administrator
U.S. Bancorp Fund Services, LLC
Advisor
REX Advisers, LLC
Custodian
U.S. Bank, N.A.
Distributor
Foreside Fund Services, LLC
Transfer Agent
U.S. Bank, N.A.
Trustee
N/A
Lead Market Maker
N/A

Miscellaneous

Beta
N/A
The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report

PEPT Sector Exposure

PEPT Industry Exposure


This page (NASDAQ:PEPT) was last updated on 10/30/2026 by MarketBeat.com Staff.
From Our Partners